Please assess the completion status of the following clinical trial:

Trial Title: ISABel: Intelligent Sleep Apnoea Bed

Study Design Characteristics:
- Allocation: None
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Documented supine positional OSA (AHIsupine/AHInonsupine ≥2) with a total AHI of ≥10 events/hour~* Age ≥18 years and \<80 years~* Written informed consent documented by signature~Exclusion Criteria:~* Previous or current use of positional therapy~* Use of home oxygen therapy~* Documented hypoventilation syndrome~* Documented Cheyne-Stokes breathing~* Documented moderate-to-severe or severe obstructive lung diseases~* Chronic heart failure~* Documented active drug or alcohol abuse~* Known or suspected non-compliance~* Inability to follow the procedures of the study, e.g. due to language problems, documented psychological disorders, documented dementia, etc. of the participant~* Current professional driver or any either documented or reported previous sleep-related driving accidents~* People working with or operating heavy machinery~* Child-bearing age: female participants who are neither surgically sterilised / hysterectomised nor post-menopausal for longer than 2 years are considered as being of child bearing potential~* Documented unstable, untreated coronary or peripheral artery disease, severe hypertension or hypotension (≥180/110 or ≤90/60 mmHg)~* BMI \>40 kg/m2 or body weight \>130 kg~* Being the investigator, his/her family members, employees, or other dependent persons

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- ISABel Bed 1 or ISABel Bed 2 (Type: OTHER): The study has a within-subject repeated measures-design. After a baseline measurement, participants will be allocated to either a first experimental night in automated bed 1 (ISABel Bed 1) and a second one in automated bed 2 (ISABel Bed 2) or a first experimental night in bed 2 and a second one in bed 1. Afterwards, the results of each polysomnographic measurement carried out during the intervention will be compared to the off-treatment baseline measurement.

Based on this trial design, predict the completion outcome and termination type (if applicable).